drugset
drugset / Trial / NCT02858219

A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia

NCT02858219 ↗

Phase 3 Completed 60 enrolled Centre Hospitalier Universitaire de Besancon
RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective of this study is to compare the efficacy of botulinum toxin injections on vestibulodynia pain compared to a group treated with a placebo.

Timeline

Start
2010-05-04
Primary completion
2019-02-11
Completion
2019-02-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu —

Indications

vulvodynia